PREOPERATIVE ASSESSMENT CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Bayou Perioperative Clinic—named for the Houston bayou system that connects hospitals and neighborhoods—operates in the perioperative medicine sector as a third-party, outpatient medical clinic. We provide comprehensive pre-surgical patient evaluations, risk stratification, point-of-care diagnostics, medication optimization, and formal surgical clearance. We partner directly with ambulatory surgery centers and community hospitals across the Greater Houston metro to manage the entire pre-operative workflow and share structured data through integrated EHR interfaces. One-liner: we optimize patients so surgeries start on time and recoveries are safer.

Our competitive edge is a focused team of physicians and advanced practice providers who work only in perioperative care, plus on-site advanced diagnostics and bi-directional EHR integration that reduce cancellations and delay. We charge a scalable fee-for-service rate to ASCs and hospitals and offer bundled pre-op packages for elective-surgery populations. Target users are ASCs, community hospitals, surgeons, and adult elective-surgery patients in Greater Houston. Short-term goals: launch operations in Q2 2026, secure two ASC partnerships, and evaluate 500 patients in year one. Long-term goals: expand regionally to five clinics by 2030, add telemedicine pre-op pathways, and standardize surgical readiness metrics across partners.

Problem

Surgical facilities nationwide face fragmented, non-standardized pre-operative assessments that cause last-minute cancellations, delays, and higher perioperative complications. These failures reduce operating room utilization, force overtime and rescheduling, and increase readmissions and complication-related costs for both hospitals and ambulatory surgery centers.

Non-standardized pre-op workups create clinical risk and measurable financial loss.

Current workflows overload surgical staff with clearance coordination, miss risk-stratification for complex cases, and lack integrated diagnostics and data sharing. Existing hospital and clinic processes rarely provide a dedicated, scalable perioperative service focused solely on medical optimization, leaving a persistent gap in throughput, clinical certainty, and margin protection.

Solution

We operate a specialized third-party medical clinic in Houston, Texas that delivers comprehensive pre-surgical evaluations and medical optimization to close the gap causing last-minute cancellations, administrative burden on surgeons, and fragmented patient experiences. Surgical facilities lose millions annually to day-of-surgery cancellations and extended stays caused by inadequate pre-op assessment.

We provide on-site exams, full medical-history review, risk assessments, testing, comorbidity optimization, and structured medical-clearance reports integrated with surgical EHRs to standardize the pre-operative phase and reduce perioperative risk.

Mission Statement

Our mission is to enhance patient safety and surgical facility efficiency through expert, standardized perioperative medical optimization. We reduce clinical and financial risks of surgery by delivering the highest level of pre-operative care and collaborating with surgical teams and facilities. We commit to evidence-based medicine, operational innovation, and dedicated partnerships to become the national leader in third-party pre-surgical evaluations. We deliver measurable value to patients, providers, and payers by ensuring every patient is medically prepared for a successful outcome.

Key Success Factors

Immediate breakeven achieved in January 2026 and a one-month payback period demonstrate our operational efficiency.

• Scaled clinical team: Grow to 58 clinical professionals by 2030 to meet demand.
• Rapid financial payback: Immediate breakeven in Jan 2026 and one-month payback.
• Integrated referral network: Partnerships with ASCs and community hospitals supported by a Sales and Relations Manager.
• Proprietary clinical protocols: Evidence-based protocols ensuring consistent medical clearances.
• Strong cash generation: Year 5 EBITDA of $22,954,000 to fund growth and market leadership.

Financial Summary

Snapshot of first five years: rapid scale, high margins, and immediate breakeven.

Financial requirement: $886,000 minimum cash (Jan-26). Performance: breakeven Jan-26; months to payback: 1; IRR 708.87%; ROE 66.13%.

Financial outlook: strong cash generation, fast payback, and scalable high-margin growth to $28.73M revenue by Year 5.

Funding Requirements

USD 886,000 is required to open and operate through month one; projected first-year revenue is USD 4,457,000 with EBITDA of USD 2,802,000, breakeven expected in month one.